References
- Egli M, Leeners B, Kruger TH. Prolactin secretion patterns: basic mechanisms and clinical implications for reproduction. Reproduction 2010;140:643–54
- Salat-Baroux J. [Recurrent spontaneous abortions]. Reprod Nutr Dev 1988;28:1555–68
- Cook CL, Pridham DD. Recurrent pregnancy loss. Curr Opin Obstet Gynecol 1995 Oct;7:357–66
- Sun L, Tao F, Hao J, et al. Vaginal bleeding in early pregnancy and associations with physical, psychological and environmental factors among Chinese women: from the C-ABC cohort study. Gynecol Obstet Invest 2012;73:330–6
- Paulson RJ. Hormonal induction of endometrial receptivity. Fertil Steril 2011;96:530–5
- Lessey BA. Assessment of endometrial receptivity. Fertil Steril 2011;96:522–9
- Kallen CB, Arici A. Immune testing in fertility practice: truth or deception? Curr Opin Obstet Gynecol 2003;15:225–31
- ASMR. Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008;89:1603
- Lepoutre T, Debieve F, Gruson D, Daumerie C. Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases. Gynecol Obstet Invest 2012;74:265–73
- Jabbour HN, Critchley HO, Boddy SC. Expression of functional prolactin receptors in nonpregnant human endometrium: janus kinase-2, signal transducer and activator of transcription-1 (STAT1), and STAT5 proteins are phosphorylated after stimulation with prolactin. J Clin Endocrinol Metab 1998;83:2545–53
- Jones RL, Critchley HO, Brooks J, et al. Localization and temporal expression of prolactin receptor in human endometrium. J Clin Endocrinol Metab 1998;83:258–62
- Jabbour HN, Critchley HO. Potential roles of decidual prolactin in early pregnancy. Reproduction 2001;121:197–205
- Bussen S, Sutterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod 1999;14:18–20
- Hirahara F, Andoh N, Sawai K, et al. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil Steril 1998;70:246–52
- Qiu X, Sun X, Christow A, et al. The effect of mifepristone on the expression of insulin-like growth factor binding protein-1, prolactin and progesterone receptor mRNA and protein during the implantation phase in human endometrium. Mol Hum Reprod 2002;8:998–1004
- Nilsson C, Eriksson E. Partial dopamine D2 receptor agonists antagonize prolactin-regulating D2 receptors in a transfected clonal cell line (GH4ZR7). Eur J Pharmacol 1992;218:205–11
- Hansen KA, Zhang Y, Colver R, et al. The dopamine receptor D2 genotype is associated with hyperprolactinemia. Fertil Steril 2005;84:711–18
- Calarge CA, Ellingrod VL, Acion L, et al. Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents. Pharmacogenet Genomics 2009;19:373–82
- Legro RS, Dietz GW, Comings DE, et al. Association of dopamine D2 receptor gene haplotypes with anovulation and fecundity in female Hispanics. Hum Reprod 1994;9:1271–5
- Perks CM, Newcomb PV, Grohmann M, et al. Prolactin acts as a potent survival factor against C2-ceramide-induced apoptosis in human granulosa cells. Hum Reprod 2003;18:2672–7
- Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004;1:6
- Li J. [Research advances in the relationship between prolactin and spontaneous abortion]. Zhong Xi Yi Jie He Xue Bao 2012;10:7–12
- Vlahos NP, Bugg EM, Shamblott MJ, et al. Prolactin receptor gene expression and immunolocalization of the prolactin receptor in human luteinized granulosa cells. Mol Hum Reprod 2001;7:1033–8
- Ormandy CJ, Camus A, Barra J, et al. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 1997;11:167–78
- Athreya BA, Zulian F, Godillot AP, et al. Prolactin receptor levels on lymphocytes vary with menstrual cycle in women. Pathobiology 1994;62:34–42
- Gubbay O, Critchley HO, Bowen JM, et al. Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium. J Clin Endocrinol Metab 2002;87:2329–35
- Novella-Maestre E, Carda C, Ruiz-Sauri A, et al. Identification and quantification of dopamine receptor 2 in human eutopic and ectopic endometrium: a novel molecular target for endometriosis therapy. Biol Reprod 2010;83:866–73
- Basu S, Nagy JA, Pal S, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001;7:569–74